|
1
|
Crone S, Vives-Flórez M, Kvich L, Saunders
AM, Malone M, Nicolaisen MH, Martínez-García E, Rojas-Acosta C,
Catalina Gomez-Puerto M, Calum H, et al: The environmental
occurrence of Pseudomonas aeruginosa. APMIS. 128:220–231.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Berger C, Rückert C, Blom J, Rabaey K,
Kalinowski J and Rosenbaum MA: Estimation of pathogenic potential
of an environmental Pseudomonas aeruginosa isolate using
comparative genomics. Sci Rep. 11(1370)2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Diggle SP and Whiteley M: Corrigendum:
Microbe profile: Pseudomonas aeruginosa: Opportunistic
pathogen and lab rat. Microbiology (Reading).
167(001073)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Shi Y, Cao Q, Sun J, Hu X, Su Z, Xu Y,
Zhang H, Lan L and Feng Y: The opportunistic pathogen
Pseudomonas aeruginosa exploits bacterial biotin synthesis
pathway to benefit its infectivity. PLoS Pathog.
19(e1011110)2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sathe N, Beech P, Croft L, Suphioglu C,
Kapat A and Athan E: Pseudomonas aeruginosa: Infections and
novel approaches to treatment ‘Knowing the enemy’ the threat of
Pseudomonas aeruginosa and exploring novel approaches to
treatment. Infect Med (Beijing). 2:178–194. 2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhang S and Stallforth P: Biofilms and
exopolysaccharides in Pseudomonas aeruginosa: Pathogenesis,
immune evasion, and lung-brain signaling during pneumonia. Signal
Transduct Target Ther. 9(204)2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Huang Q, Duan C, Ma H, Nong C, Zheng Q,
Zhou J, Zhao N, Mou X, Liu T, Zou S, et al: Structural and
functional characterization of itaconyl-CoA hydratase and
citramalyl-CoA lyase involved in itaconate metabolism of
Pseudomonas aeruginosa. Structure. 32:941–952.e3.
2024.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Maruri-Aransolo A, López-Causapé C,
Hernández-García M, García-Castillo M, Caballero-Pérez JD, Oliver A
and Cantón R: In vitro activity of cefiderocol in Pseudomonas
aeruginosa isolates from people with cystic fibrosis recovered
during three multicentre studies in Spain. J Antimicrob Chemother.
79:1432–1440. 2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ashworth EA, Wright RCT, Shears RK, Wong
JKL, Hassan A, Hall JPJ, Kadioglu A and Fothergill JL: Exploiting
lung adaptation and phage steering to clear pan-resistant
Pseudomonas aeruginosa infections in vivo. Nat Commun.
15(1547)2024.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Siukstaite L, Imberty A and Römer W:
Structural diversities of lectins binding to the glycosphingolipid
Gb3. Front Mol Biosci. 8(704685)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Schubert T, Sych T, Madl J, Xu M, Omidvar
R, Patalag LJ, Ries A, Kettelhoit K, Brandel A, Mely Y, et al:
Differential recognition of lipid domains by two Gb3-binding
lectins. Sci Rep. 10(9752)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Üçeyler N, Böttger J, Henkel L, Langjahr
M, Mayer C, Nordbeck P, Wanner C and Sommer C: Detection of blood
Gb3 deposits as a new tool for diagnosis and therapy monitoring in
patients with classic Fabry disease. J Intern Med. 284:427–438.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Dinu IR and Firu ŞG: Fabry disease-current
data and therapeutic approaches. Rom J Morphol Embryol. 62:5–11.
2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bichet DG, Aerts JM, Auray-Blais C,
Maruyama H, Mehta AB, Skuban N, Krusinska E and Schiffmann R:
Assessment of plasma lyso-Gb3 for clinical monitoring of
treatment response in migalastat-treated patients with Fabry
disease. Genet Med. 23:192–201. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Nowak A, Beuschlein F, Sivasubramaniam V,
Kasper D and Warnock DG: Lyso-Gb3 associates with adverse long-term
outcome in patients with Fabry disease. J Med Genet. 59:287–293.
2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhang T, de Waard AA, Wuhrer M and Spaapen
RM: The Role of glycosphingolipids in immune cell functions. Front
Immunol. 10(90)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Freedman SB, van de Kar N and Tarr PI:
Shiga toxin-producing escherichia coli and the hemolytic-uremic
syndrome. N Engl J Med. 389:1402–1414. 2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Park JY, Kim CH and Cho SH:
Glycan-adhering lectins and experimental evaluation of a lectin
fimh inhibitor in enterohemorrhagic Escherichia coli (EHEC)
O157:H7 strain EDL933. Int J Mol Sci. 23(9931)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Arenas-Mosquera D, Pinto A, Cerny N,
Berdasco C, Cangelosi A, Geoghegan PA, Malchiodi EL, De Marzi M and
Goldstein J: Cytokines expression from altered motor thalamus and
behavior deficits following sublethal administration of Shiga toxin
2a involve the induction of the globotriaosylceramide receptor.
Toxicon. 216:115–124. 2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zheng S, Eierhoff T, Aigal S, Brandel A,
Thuenauer R, de Bentzmann S, Imberty A and Römer W: The
Pseudomonas aeruginosa lectin LecA triggers host cell
signalling by glycosphingolipid-dependent phosphorylation of the
adaptor protein CrkII. Biochim Biophys Acta Mol Cell Res.
1864:1236–1245. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kociurzynski R, Makshakova ON, Knecht V
and Römer W: Multiscale molecular dynamics studies reveal different
modes of receptor clustering by Gb3-binding lectins. J Chem Theory
Comput. 17:2488–2501. 2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Feitz WJC, Bouwmeester R, van der Velden
TJAM, Goorden S, Licht C, van den Heuvel LPJW and van de Kar NCAJ:
The shiga toxin receptor globotriaosylceramide as therapeutic
target in Shiga Toxin E. coli Mediated HUS. Microorganisms.
9(2157)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Brandel A, Aigal S, Lagies S, Schlimpert
M, Meléndez AV, Xu M, Lehmann A, Hummel D, Fisch D, Madl J, et al:
The Gb3-enriched CD59/flotillin plasma membrane domain regulates
host cell invasion by Pseudomonas aeruginosa. Cell Mol Life
Sci. 78:3637–3656. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gao S, Ni C, Huang W, Hao H, Jiang H, Lv
Q, Zheng Y, Liu P, Kong D and Jiang Y: The interaction between
flagellin and the glycosphingolipid Gb3 on host cells contributes
to Bacillus cereus acute infection. Virulence. 11:769–780.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Szymczak-Kulus K, Czerwinski M and
Kaczmarek R: Human Gb3/CD77 synthase: A glycosyltransferase at the
crossroads of immunohematology, toxicology, and cancer research.
Cell Mol Biol Lett. 29(137)2024.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Geyer PE, Maak M, Nitsche U, Perl M,
Novotny A, Slotta-Huspenina J, Dransart E, Holtorf A, Johannes L
and Janssen KP: Gastric adenocarcinomas express the
glycosphingolipid Gb3/CD77: Targeting of gastric cancer cells with
Shiga Toxin B-subunit. Mol Cancer Ther. 15:1008–1017.
2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Pulmonary Infection Assembly of Chinese
Thoracic Society. Chinese expert consensus on the management of
lower respiratory tract infections of Pseudomonas aeruginosa
in adults (2022). Zhonghua Jie He He Hu Xi Za Zhi. 45:739–752.
2022.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
28
|
Sharma P, Zhang X, Ly K, Zhang Y, Hu Y, Ye
AY, Hu J, Kim JH, Lou M, Wang C, et al: The lipid
globotriaosylceramide promotes germinal center B cell responses and
antiviral immunity. Science. 383(eadg0564)2024.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Weinbergerova B, Kabut T, Kocmanova I,
Lengerova M, Pospisil Z, Kral Z and Mayer J: Bronchoalveolar lavage
fluid and serum 1,3-β-D-glucan testing for invasive pulmonary
aspergillosis diagnosis in hematological patients: The role of
factors affecting assay performance. Sci Rep.
10(17963)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gan Q, Li Z, Li X, Huang Y and Deng H:
Analysis of the effects of early screening combined with blood
lactate on the severity of patients with sepsis. Heliyon.
10(e31907)2024.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Formenti P, Gotti M, Palmieri F, Pastori
S, Roccaforte V, Menozzi A, Galimberti A, Umbrello M, Sabbatini G
and Pezzi A: Presepsin in critical illness: Current knowledge and
future perspectives. Diagnostics (Basel). 14(1311)2024.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Hu Y, Ren J, Lv Z, Liu H and Qiu X:
Procalcitonin and C-reactive protein as early predictors in
patients at high risk of colorectal anastomotic leakage. J Int Med
Res. 52(3000605241258160)2024.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zeng Y, Xie Y, Chen D and Wang R: Related
factors of euthyroid sick syndrome in patients with sepsis. Beijing
Da Xue Xue Bao Yi Xue Ban. 56:526–532. 2024.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
34
|
Müller DC, Kauppi A, Edin A, Gylfe Å,
Sjöstedt AB and Johansson A: Phospholipid levels in blood during
community-acquired pneumonia. PLoS One. 14(e0216379)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Nan W, Xiong F, Zheng H, Li C, Lou C, Lei
X, Wu H, Gao H and Li Y: Myristoyl lysophosphatidylcholine is a
biomarker and potential therapeutic target for community-acquired
pneumonia. Redox Boil. 58(102556)2022.PubMed/NCBI View Article : Google Scholar
|
